Compare DSWL & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DSWL | ELUT |
|---|---|---|
| Founded | 1987 | 2015 |
| Country | Macau | United States |
| Employees | N/A | N/A |
| Industry | Plastic Products | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.9M | 48.3M |
| IPO Year | 2000 | 2020 |
| Metric | DSWL | ELUT |
|---|---|---|
| Price | $3.35 | $1.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 11.3K | ★ 67.0K |
| Earning Date | 11-13-2025 | 05-08-2026 |
| Dividend Yield | ★ 5.88% | N/A |
| EPS Growth | N/A | ★ 146.77 |
| EPS | N/A | ★ 0.87 |
| Revenue | N/A | ★ $12,293,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.83 |
| P/E Ratio | $4.59 | ★ $1.20 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.03 | $0.50 |
| 52 Week High | $4.48 | $2.60 |
| Indicator | DSWL | ELUT |
|---|---|---|
| Relative Strength Index (RSI) | 53.08 | 37.53 |
| Support Level | $3.24 | $1.00 |
| Resistance Level | $3.40 | $1.16 |
| Average True Range (ATR) | 0.14 | 0.06 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 42.08 | 0.00 |
Deswell Industries Inc is engaged in the manufacturing and selling of injection-molded plastic parts and components. In addition, it also offers manufacturing services for electronic products and subassemblies and manufactures metallic molds and accessory parts for original equipment manufacturers and contract manufacturers. The company conducts all of its manufacturing activities at separate plastics, electronics and metallic operation factories located in the People's Republic of China. It operates through the Plastic Injection Molding and Electronic Products Assembling segments. The firm offers products such as automobile components, medical testing equipment, parts for audio equipment, av receivers, active subwoofers, digital system key sets, communication products and others.
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.